Cohort 2 offspring body and brain morphometric measurements following maternal treatment with naltrexone or placebo implants.

Morphometric effects of maternal treatments during pregnancy and/or weaning on offspring body parameters (body weight, foot and head lengths), at birth and in adulthood (at 8 weeks-of-age). Morphometric effects on brain parameters (brain [cerebral+cerebellar] weight, volume and length, and cerebral length, height and width) are shown for adult male and female offspring and all values represent the mean ± SEM. Using one-way ANOVA: *** p†p = 0.04, trend for difference between naltrexone versus placebo; § p